Procedures using surgical matrices rebounded to normal levels again, with broad strength in both hernia and breast matrices.
Procedures using surgical matrices returned to approximately normal levels, though the Delta variant may make that recovery short-lived, as recently observed in Texas. The US Surgical Matrices market rebounded strongly in Q221 according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* continued to lead the US Surgical Matrices market, with Becton Dickinson* (BD) bouncing back nearly as strongly.
Among the many topics covered in detail in our comprehensive Q221 US Surgical Matrices Market Recap* are: